Encision Inc. (OTCMKTS:ECIA) Upgraded to “Hold” at ValuEngine

ValuEngine upgraded shares of Encision Inc. (OTCMKTS:ECIA) from a sell rating to a hold rating in a research note issued to investors on Saturday, July 22nd.

Shares of Encision (OTCMKTS ECIA) traded up 11.69% during mid-day trading on Friday, reaching $0.43. 44,000 shares of the company were exchanged. Encision has a 12 month low of $0.18 and a 12 month high of $0.52. The firm’s market capitalization is $4.59 million. The company’s 50-day moving average is $0.40 and its 200 day moving average is $0.39.

Encision (OTCMKTS:ECIA) last issued its earnings results on Thursday, July 27th. The medical device company reported $0.02 earnings per share (EPS) for the quarter. Encision had a negative return on equity of 22.86% and a negative net margin of 5.00%. The firm had revenue of $2.36 million for the quarter.

ILLEGAL ACTIVITY NOTICE: This report was originally reported by BNB Daily and is owned by of BNB Daily. If you are reading this report on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.baseball-news-blog.com/2017/08/19/encision-inc-otcmktsecia-raised-to-hold-at-valuengine-updated-updated-updated.html.

About Encision

Encision Inc is a medical device company. The Company designs, develops, manufactures and markets surgical instruments that provide safety to patients undergoing minimally-invasive surgery. Its Active Electrode Monitoring (AEM) technology provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures, while preventing stray electrosurgical energy that can cause complications and even death.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Encision Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encision Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply